(This story was updated on October 23 with a statement from Amgen. It was again updated on October 27 with new information about Amgen’s patient privacy policy for a second drug, Enbrel.) The tumult over the new cholesterol drugs just got a little more tumultuous. In addition to the existing controversies involving the high cost...
Click here to continue reading...
Click here to continue reading...